Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Powered Echelon Device in VATS Surgery

NCT01843192

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Dignity Health, St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer

NCT00867009

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Graz, Austria
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salzburg, Austria
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wels, Austria
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
View all 24 locations
View Trial Details
Completed

Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC

NCT00621049

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Northeast Alabama Medical Center Anniston, Alabama, United States
  • Northeast Arkansas Clinic Jonesboro, Arkansas, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Gulfcoast Oncology Associates St. Petersburg, Florida, United States
View all 26 locations
View Trial Details
Completed

A Study of LY2875358 in Japanese Participants With Advanced Cancer

NCT01602289

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
View Trial Details
Completed

A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)

NCT01562015

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Synta Pharmaceuticals Investigative Site Tampa, Florida, United States
  • Synta Pharmaceuticals Investigative Site Cleveland, Ohio, United States
  • Synta Pharmaceuticals Investigative Site Hamilton, Ontario, Canada
  • Synta Pharmaceuticals Investigative Site Ottawa, Ontario, Canada
View Trial Details

Related conditions